![Eric S. Hoffman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric S. Hoffman
Corporate Officer/Principal chez
FUSN PHAR
Profil
Eric S.
Hoffman is currently the Senior Vice President-Business Development at Fusion Pharmaceuticals, Inc. He previously worked as the Director-Corporate & Business Development at Biogen, Inc. from 2006 to 2011, and as the Vice President-Corporate & Business Development at Idenix Pharmaceuticals LLC from 2011 to 2014.
He also served as a Research Analyst at JPMorgan Securities LLC.
From 2014 to 2018, he was the Chief Business Officer at Genocea Biosciences, Inc. and later became the Chief Business Officer at Vicarius Pharma AG.
Dr. Hoffman received his undergraduate degree from Trinity University and his doctorate from Yale University.
Postes actifs de Eric S. Hoffman
| Sociétés | Poste | Début |
|---|---|---|
| FUSN PHAR | Corporate Officer/Principal | 21/09/2021 |
Anciens postes connus de Eric S. Hoffman
| Sociétés | Poste | Fin |
|---|---|---|
| GENOCEA BIOSCIENCES, INC. | Corporate Officer/Principal | 01/09/2018 |
| IDENIX PHARMACEUTICALS INC | Investor Relations Contact | 22/05/2013 |
| BIOGEN INC. | Public Communications Contact | 01/03/2010 |
Vicarius Pharma AG
 Vicarius Pharma AG Miscellaneous Commercial ServicesCommercial Services Provides research and development services for pharmaceutical, biotech and medical companies | Corporate Officer/Principal | - |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance Provides corporate, investment banking, consumer and commercial banking, asset management, payment & security solutions | Analyst-Equity | - |
Formation de Eric S. Hoffman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Trinity University
 Trinity University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance Provides corporate, investment banking, consumer and commercial banking, asset management, payment & security solutions | Finance |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
Vicarius Pharma AG
Vicarius Pharma AG Miscellaneous Commercial ServicesCommercial Services Provides research and development services for pharmaceutical, biotech and medical companies | Commercial Services |
